Company / Return on Equity (ROE)
MANGOCEUTICALS, INC. Return on Equity (ROE) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-135.8%
FY2025
5-year range
-257.9% / -66.1%
FY2023-FY2025
Trend
-105.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
MANGOCEUTICALS, INC. reports negative total equity of -135.8% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-135.8% in FY2025.
Improved from -257.9% to -135.8% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 105.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -135.8% | -105.6% |
| FY2024 | -66.1% | +74.4% |
| FY2023 | -257.9% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026